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INTRODUCTION
The majority of diseases in dairy cows are treated by application of antibiotic
treatment. Spain is the third country on sales of veterinary antimicrobial agents
in Europe.
Mastitis is the most common disease of dairy cows and is the main reason why
cows are treated with antibiotics. Nowadays, pressure to reduce their use in
livestock is increasing due to problems derived from the treatment with
antibiotics and their impact on public health: emergence of pathogenic
organisms resistant to antimicrobials and the presence of antibiotic residues.
Pathogens (Table 1) causing mastitis can be divided into 2 groups: contagious
and opportunistic or environmental.
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OBJECTIVES
 The aim of this research is to review the use of antibiotics to treat and
prevent commonly occurring infections
 Make recommendations to reduce the use of antimicrobial agents
Staphylococcus 
aureus
Streptococcus 
uberis
Coliforms
Catalonia 6,4 % (1) 9,4 % (1) 9,5 % (1)
Germany 10 % (2) 8.5 % (2) 10.2 % (2)
France 15.8 % (2) 22.1 % (2) 16 % (2)
Netherlands 18.9 % (2) (3) 9.6 % (2) 28 % (3)
Sweden 28.4 % (2) 15.2 % (2) 21.9 % (2)
United Kingdom 3 % (3) 25 % (3) 21 % (3)
Spain 15.5 % (4) 8.% (4) -
(1) ALLIC, 2016 ; (2) Thomas et al., 2015; (3) Ruegg, 2014; (4) Marco et al., 2000
Table 2. Most common pathologies
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 Antibiotic use questionnaire
was conducted between
February and April 2016 in 10
dairy herds in Girona.
 Representing 2% of farms in
Catalonia and contain 13.5%
of cattle in Girona.
 The sample size does not
allow a statistical study with
the corresponding statistical
tests.
RESULTS AND DISCUSSION
Herd size ranged from 100 to 910 cows, averaging 429 cows. Seven of the herds
were housed in freestalls and 3 in bedded housing system. Annual milk
production among those herds ranged from 9.647 L to 11.800 L, averaging
10.884 L. Bulk tank milk SCC ranged from 185.000 cells/mL to 371.000 cells/mL,
averaging 253.000 cells/mL.
Regarding the different pathologies present in farms, the predominant disease
is mastitis, followed by lameness (Table 2).
Antimicrobial
classes
Drug Nº  farms
Fluoroquinolones Enrofloxacin 7
Lincosamins Lincomycin 1
β-lactam
Penicillin 7
Cephalosporin 1st G 1
Cephalosporin 3rd – 4th G 1
Aminoglycosides
Neomycin 1
Kanamycin 1
Streptomycin 1
Framicetin 1
Pathologies
Farm
Size 
(milking 
cows)
Mastitis 
per year 
(%)
New 
cases 
mastitis 
(%)
Repetitive 
cases (%)
Metritis
(% )
Lameness 
(%)
Ketosis 
(%)
1 840 56,7 30,7 46 18,8 34,5 0
2 751 55,1 33,9 38,9 15 68,5 22,2
3 712 29,4 26,2 10,9 - 13,6 1,5
4 209 15 14 6,7 - 7 -
5 123 25 23 8 - - -
6 145 - 40 - 1,5 25 -
7 470 65 45 30,7 5 1 1
8 215 12 - - 2 3,5 1
9 94 34 25,84 24 10,3 14,5 -
10 356 103,5 53,4 48,5 16,8 22,5 -
Average 391,5 47,96 31,51 26,7 13,18 23,09 -
SD 284,09 30,81 15,34 18,74 7,57 20,70 -
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Farm Selection criteria
Evaluation of 
effectivity
Regular
rotation?
Prescription
1 withdrawal period Subjective No
Herd 
veterinarian
2 withdrawal period Subjective No Vet com.
3 Price Subjective No Vet com.
4 Price Subjective No Vet com.
5 Price Not evaluated No Vet com.
6 Price Not evaluated No Vet com.
7 Price Subjective No Vet com.
8 effectivity Subjective No Vet com.
9 withdrawal period Subjective No Vet com.
10 withdrawal period Subjective No
Herd 
veterinarian
 Mastitis is the most prevalent disease on farms studied, as is shown by the results
obtained.
 Farmers has an easy way to buy antimicrobials, but this will change with the new
legislation.
 Some questionable treatments are routinely carried out on farms studied as
treatments with last choice drugs.
 Measures to reduce antimicrobial use can be adopted:
Administering intramammary infusions instead of systemic treatments
 Implementation of a selective drying treatment and applying non-antibiotic 
sealants may be another alternative 
 Reduce the use of antibiotics causes a decrease in resistance and a lower risk of
transferring to people.
CONCLUSIONS
Table 1. Percentage of isolation of most common pathogens
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June 2016
Table 3. Drugs most commonly used in farmsMany producers are
treating clinical mastitis
with intramuscular or
subcutaneous drugs
alone. Supplying last
choice treatments (7/10)
as fluorquinolones rather
than treating with first
choice drugs (penicillin
or 1st G Cephalosporin)
intramammary (Table 3).
The use of fluorquinolones and 3rd generation cephalosporin increases the risk of
emergence of resistant pathogens and should not be used as 1st option. Following Prudent
Use Guidelines fluoroquinolones should be reserved for the treatment of clinical
conditions that have responded poorly, or are expected to respond poorly, to other classes
of antimicrobials and should only be used where susceptibility testing has first been
carried out.
Figure 1. Distribution of dairy cows on 
Catalonia. Prepared by the author
Table 4. Use of antibiotics on farm
Figure 2. Percentage of resistance to most common drugs used on farms. Data shows there is a
big presence of resistance to most common drugs used on farms, mainly to Penicillin and
Ampicillin. E coli shows resistance, and has the biggest percentage of resistance, to a wider
range of drugs. Data from antibiogram results realized by ALLIC during 2015 (n=67).
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